カテゴリ： MarketLine, カナダ, 企業調査

AltaGas Ltd.：企業の戦略・SWOT・財務分析

◆英語タイトル：AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4177
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：カナダ
◆産業分野：Energy and Utilities
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AltaGas Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

AltaGas Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AltaGas Ltd. (AltaGas or ‘the company’) is a diversified energy infrastructure business with a focus on natural gas, power, and regulated utilities. The company generates electricity from diverse fuel sources, including run-of-river hydro, wind, geothermal and gas-fired generation plants. AltaGas owns and operates utility assets to deliver natural gas to end-users in the US and Canada. The company serves small commercial and residential customers. It has presence in British Columbia, Alberta, Michigan, Alaska, Nova Scotia, and provinces in the US and Canada. It is headquartered in Alberta, Canada.

Scope

- Detailed information on AltaGas Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AltaGas Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of AltaGas Ltd. including a breakdown and examination of key business segments
- Intelligence on AltaGas Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AltaGas Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AltaGas Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AltaGas Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AltaGas Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
AltaGas Ltd.: Company Overview
AltaGas Ltd.: Overview and Key Facts
AltaGas Ltd.: Overview
AltaGas Ltd.: Key Facts
AltaGas Ltd.: Key Employees
AltaGas Ltd.: Key Employee Biographies
AltaGas Ltd.: Major Products and Services
AltaGas Ltd.: Company History
AltaGas Ltd.: Management Statement
AltaGas Ltd.: Key Competitors
AltaGas Ltd.: Company Analysis
AltaGas Ltd.: Business Description
AltaGas Ltd.: SWOT Analysis
AltaGas Ltd.: SWOT Overview
AltaGas Ltd.: Strengths
AltaGas Ltd.: Weaknesses
AltaGas Ltd.: Opportunities
AltaGas Ltd.: Threats
AltaGas Ltd.: Corporate Financial Deals Activity
AltaGas Ltd.: Financial Deals Overview
AltaGas Ltd.: Targets and Partners
AltaGas Ltd.: Top Deals 2016 – 2020YTD*
AltaGas Ltd.: Advisors
AltaGas Ltd.: Top Legal Advisors
AltaGas Ltd.: Top Financial Advisors
AltaGas Ltd.: Mergers and Acquisitions
AltaGas Ltd.: Corporate Venturing
AltaGas Ltd.: Capital Raising
AltaGas Ltd.: Divestments
AltaGas Ltd.: Recent Developments
AltaGas Ltd.: News and Events Summary
AltaGas Ltd.: Business Expansion
AltaGas Ltd.: Contracts
AltaGas Ltd.: Corporate Governance
AltaGas Ltd.: Corporate Social Responsibility
AltaGas Ltd.: Financial Deals
AltaGas Ltd.: Regulatory and Legal Events
AltaGas Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: AltaGas Ltd.: Key Facts
Table 2: AltaGas Ltd.: Key Employees
Table 3: AltaGas Ltd.: Company History
Table 4: AltaGas Ltd.: Key Competitors
Table 5: AltaGas Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: AltaGas Ltd.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: AltaGas Ltd.: M&A Average Deal Size - Value (US$m)
Table 8: AltaGas Ltd.: Targets and Partners
Table 9: AltaGas Ltd.: Top Deals 2016 - 2020YTD*
Table 10: AltaGas Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: AltaGas Ltd.: Financial Advisor Ranking by Value (US$m)
Table 12: AltaGas Ltd.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: AltaGas Ltd.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 14: AltaGas Ltd.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 15: AltaGas Ltd.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: AltaGas Ltd.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: AltaGas Ltd.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 18: AltaGas Ltd.: Divestments by Geography (2016 - YTD*2020)
Table 19: AltaGas Ltd.: News and Events Summary
Table 20: AltaGas Ltd.: Business Expansion
Table 21: AltaGas Ltd.: Contracts
Table 22: AltaGas Ltd.: Corporate Governance
Table 23: AltaGas Ltd.: Corporate Social Responsibility
Table 24: AltaGas Ltd.: Financial Deals
Table 25: AltaGas Ltd.: Regulatory and Legal Events
Table 26: AltaGas Ltd.: Strategy and Operations

★海外企業調査レポート[AltaGas Ltd.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • DiaMedica Therapeutics Inc (DMA)：企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • NuStar Energy L.P.：企業の戦略・SWOT・財務分析
    NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report Summary NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lumenis Ltd：企業の戦略的SWOT分析
    Lumenis Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • AzurRx BioPharma Inc (AZRX)：企業の財務・戦略的SWOT分析
    AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pakistan Refinery Ltd (PRL)：企業の財務・戦略的SWOT分析
    Pakistan Refinery Ltd (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Syndax Pharmaceuticals Inc (SNDX)：企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Aesculap Inc-医療機器分野：企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Fresnillo Plc：企業の戦略・SWOT・財務情報
    Fresnillo Plc - Strategy, SWOT and Corporate Finance Report Summary Fresnillo Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Molnlycke Health Care AB：企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • MI Bioresearch Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc, is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous …
  • MallInckrodt Plc (MNK)：製薬・医療：M&Aディール及び事業提携情報
    Summary Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neur …
  • Singapore Telecommunications Ltd (Z74)：企業の財務・戦略的SWOT分析
    Singapore Telecommunications Ltd (Z74) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Oriental Bank of Commerce：企業のM&A・事業提携・投資動向
    Oriental Bank of Commerce - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Oriental Bank of Commerce Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Alethia Biotherapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products comprise AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitors. It also offers therapeuti …
  • TVA Medical Inc：医療機器：M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • Abdullah Al-Othaim Markets Co.：企業の戦略・SWOT・財務情報
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CaroGen Corp-製薬・医療分野：企業M&A・提携分析
    Summary CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle th …
  • IDBI Bank Ltd：企業のM&A・事業提携・投資動向
    IDBI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IDBI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Sprint Corporation：企業の戦略・SWOT・財務分析
    Sprint Corporation - Strategy, SWOT and Corporate Finance Report Summary Sprint Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • National Institute on Drug Abuse-製薬・医療分野：企業M&A・提携分析
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆